[T- and B-lymphocytes, interleukins and natural killers in patients with osteomyelitis developing after combined injuries to the maxillofacial and craniocerebral areas].
Forty-three patients with traumatic osteomyelitis developing after combined maxillofacial and craniocerebral injuries and thirty normal subjects were examined. Immunologic findings permit distinguishing two groups of patients: those with marked disorders of the T cellular immunity (reduced T helper and Tx counts, interleukin-2 synthesis, and Tx/T suppressor coefficient) and without such shifts. The therapy of patients without manifest immunity shifts was generally effective whereas in those with marked immunity disorders the therapy efficacy was inadequate and the immunity disorders persisted.
V P
VP
Zuev
L A
LA
Grigor'iants
L L
LL
Litvinova
V V
VV
Eremeev
B R
BR
Rakhmetov
D001402:B-Lymphocytes / Q000276:immunology*; D001930:Brain Injuries / Q000150:complications / Q000276:immunology*; D006801:Humans; D007113:Immunity, Innate / Q000276:immunology; D007378:Interleukins / Q000097:blood*; D007694:Killer Cells, Natural / Q000276:immunology*; D008446:Maxillofacial Injuries / Q000150:complications / Q000276:immunology*; D009104:Multiple Trauma / Q000150:complications / Q000276:immunology*; D010019:Osteomyelitis / Q000209:etiology / Q000276:immunology*; D013601:T-Lymphocytes / Q000276:immunology*
D007378:Interleukins
T- i B-limfotsity, interleĭkiny i estestvennye killery u bol'nykh s osteomielitom, razvivshimsia posle sochetannykh povrezhdeniĭ cheliustno-litsevoĭ i cherepno-mozgovoĭ oblasteĭ.